SHARE
COPY LINK
For members

COVID-19

‘Over a million people’ in Switzerland could be infected with Covid this summer

Though Covid has not been a nationwide problem in Switzerland during recent several months, the virus is circulating again and rates of contamination are expected to soar in the coming weeks.

'Over a million people' in Switzerland could be infected with Covid this summer
Déjä-vu: Could this be part of our summer this year? Image by Marcos Cola from Pixabay

While the new wave has not been expected to hit before fall or winter,  Swiss health officials now say 15 percent of Swiss population — more than 1 million people — could catch the virus before then.

This is a large number, considering that a total of 3.7 million people in Switzerland got infected since the beginning of the pandemic on February 24th, 2020.

“More than 80,000 new contaminations per week” are expected in the next two months, according to Tanja Stadler, the former head of the Covid-19 Task Force — much more than during the past two summers, when the rate of infections slowed down.

At the moment, the Federal Office of Public Health (FOPH) reports 24,704 new cases in the past seven days — double of what it was in April.

“The numbers are expected to continue to rise. Note that most of infected people will not be tested, so the number of confirmed cases will be smaller on paper than in reality”, Stadler added.

Although according to FOPH, nearly all cases in Switzerland (99 percent) are caused by Omicron and its sub-variants, which are less severe that the original Covid viruses, “more vulnerable people are likely to end up in hospital, and long Covid cases are also likely to rise”, she said.

Stadler also noted that Omicron virus can’t be compared with the flu, “because we observe long-term consequences much more often during an infection with Omicron than during the flu. Also, Covid can trigger very large waves, even in summer, while large flu outbreaks are rare at this time of year”.

There is, however, some positive news.

“The most recent data shows that 97 percent of the adult population in Switzerland has antibodies against Covid thanks to vaccinations and previous infections”, Stadler said.

Also, “in the long term, things will stabilise. But in the years to come, there will probably be waves in the summer too”.

READ MORE: UPDATE: When will Switzerland roll out second Covid boosters?

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19 VACCINES

Switzerland to start dual-strain Covid boosters in October

The long-awaited second booster shots will be rolled in Switzerland from October 10th, the Health Ministry announced on Friday.

Switzerland to start dual-strain Covid boosters in October

Less than two weeks after drug regulator Swissmedic approved the new version of the Moderna vaccine, which should better target certain sub-variants of Omicron, the Federal Office of Public Health (FOPH) said on Friday the shots will be available to some groups of the population from October 10th.

“The vaccination recommendation for autumn 2022 aims primarily to protect vulnerable people against a severe form of the disease. On the one hand, people aged 65 or over, and on the other hand, those aged 16 to 64 with an increased risk, for example due to a pre-existing disease or pregnancy”; FOPH said in a statement on Friday.

After that, those “aged 16 to 64, without risk factors and who work in acute and long-term care, or who care for vulnerable people in a professional or private capacity” will be eligible for the shots, FOPH said.Health officials noted that while the number of Covid infection is currently “relatively low, an increase in transmissions of the virus is expected from the fall of 2022. The risk of contracting Covid-19 and the burden for the health system could therefore increase again”.

It added, however, that “the situation differs markedly from that of the last two winters; currently, 97 percent of the population have antibodies against Covid following vaccination or recovery. “People without risk factors are unlikely to develop severe symptoms this fall”.

Dual-strain vaccine

In recent trials, the new Moderna vaccine demonstrated “higher antibody concentrations against the Omicron variants” than the manufacturer’s original Covid vaccine, Swissmedic said.

The previous vaccine was effective against early strains, like Alpha and Delta, offering no immunity against Omicron or its sub-variants, which are currently responsible for all the coronavirus infections detected in Switzerland.

“Compared to the original vaccine, trials have shown that this [vaccine] produces a stronger immune response against the Omicron variants BA.1 and BA.4/5″, Swissmedic said, adding that the new vaccine remains as effective as its predecessor against the original Covid viruses.

Additionally, “a careful review of the application documents submitted on an ongoing basis showed that the vaccine meets the safety, efficacy and quality requirements », the agency noted.

Also, in terms of secondary effects, they are expected to be “similar” to those following administration of the second dose and the first the booster of the original vaccine: fever, muscle pains, and headaches.

According to FOPH, “the bivalent mRNA vaccines, which are tailored to the Omicron BA.1 variant, should be preferred for booster vaccination. However, it is still possible to use the current monovalent mRNA vaccine”.

Additionally, protein-based Nuvaxovid doses will also be available.

READ MORE: BREAKING: Switzerland approves new Covid-19 boosters
 
 

SHOW COMMENTS